Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 1/20 | 0.33 |
| ▸ | ADRB2 | P07550 | 8/20 | 0.32 |
| ▸ | MPL | P40238 | 4/20 | 0.32 |
| ▸ | CHKA | P35790 | 1/20 | 0.32 |
| ▸ | ADRB1 | P08588 | 2/20 | 0.31 |
| ▸ | RARB | P10826 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12822688 | 1.00 | ALOX5 (0.33) | ALOX5ADRB2MPLCHKAADRB1 | |
| SCHEMBL12822830 | 0.90 | CYP17A1 (0.41) | ADRB2RARB | |
| SCHEMBL10303034 | 0.90 | ADRB2 (0.35) | ALOX5ADRB2MPLADRB1RARB | |
| SCHEMBL10302991 | 0.90 | ADRA2A (0.33) | ALOX5ADRB2MPLCHKAADRB1 | |
| SCHEMBL12716550 | 0.88 | CYP17A1 (0.33) | ADRB2ADRB1 | |
| SCHEMBL12822732 | 0.87 | HCAR2 (0.37) | ADRB2RARB | |
| SCHEMBL12823658 | 0.86 | BRS3 (0.31) | ALOX5MPL | |
| SCHEMBL13586170 | 0.85 | FFAR4 (0.35) | CHKA | |
| SCHEMBL12717002 | 0.85 | FFAR4 (0.35) | CHKA | |
| SCHEMBL12822397 | 0.85 | CYP17A1 (0.38) | ALOX5ADRB2MPLRARB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110090450-A1 | FOUR-RING LIQUID CRYSTAL COMPOUND HAVING LATERAL FLUORINE, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE | JNC CORPORATION (JP) | 2011-04-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110090450-A1 | FOUR-RING LIQUID CRYSTAL COMPOUND HAVING LATERAL FLUORINE, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE | LEF1, LAS1L, EFHD2 | ALOX5 830/4885ADRB2 526/4885MPL 4673/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.